Urine-Based Spectroscopy/AI Platform for Early Detection of Multiple Cancers.

IF 1.2 4区医学 Q4 ENGINEERING, BIOMEDICAL

IEEE Pulse Pub Date : 2026-01-01 DOI:10.1109/MPULS.2026.3659871

Leslie Mertz

引用次数: 0

Abstract

A new test uses artificial intelligence to identify cancer-indicative patterns of volatile organic compounds in urine. The test received U.S. FDA breakthrough device designation for early bladder cancer detection. The test is also designed for the early detection of other cancers including colorectal, stomach, pancreatic, prostate, kidney, bladder, breast, ovarian, cervical, and lung cancers.

查看原文本刊更多论文

基于尿液的光谱/人工智能平台早期检测多种癌症。

一项新的测试使用人工智能来识别尿液中挥发性有机化合物的癌症指示模式。该检测被美国食品药品监督管理局认定为早期膀胱癌检测的突破性设备。该检测还可用于其他癌症的早期检测，包括结肠直肠癌、胃癌、胰腺癌、前列腺癌、肾癌、膀胱癌、乳腺癌、卵巢癌、宫颈癌和肺癌。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

IEEE Pulse ENGINEERING, BIOMEDICAL-

CiteScore

1.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： IEEE Pulse covers both general and technical articles on current technologies and methods used in biomedical and clinical engineering; societal implications of medical technologies; current news items; book reviews; patent descriptions; and correspondence. Special interest departments, students, law, clinical engineering, ethics, new products, society news, historical features and government.